{"name":"Zhuhai Beihai Biotech Co., Ltd","slug":"zhuhai-beihai-biotech-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BH009 (Docetaxel injection)","genericName":"BH009 (Docetaxel injection)","slug":"bh009-docetaxel-injection","indication":"Metastatic breast cancer","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"BH009","genericName":"BH009","slug":"bh009","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"BH009 (Docetaxel injection)","genericName":"BH009 (Docetaxel injection)","slug":"bh009-docetaxel-injection","phase":"phase_3","mechanism":"Docetaxel stabilizes microtubules by binding to β-tubulin, preventing their depolymerization and disrupting cell division.","indications":["Metastatic breast cancer","Non-small cell lung cancer","Prostate cancer","Gastric cancer","Head and neck cancer"],"catalyst":""},{"name":"BH009","genericName":"BH009","slug":"bh009","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE1rQnJGN2RFYXZKcGVPeWlMSUtGRVJnRHdxOGlGc1RMOGt3N01Za2N0LUtoLUg2LU9FNng3WFhXdlRPYXFTTkNVMW14QmpPZWcxM0VnZ180QXV2NkplNFFTZ0t3?oc=5","date":"2025-10-24","type":"pipeline","source":"HKTDC Research","summary":"Biomedicine Boost As Zhuhai Links Up With Hong Kong and Macao - HKTDC Research","headline":"Biomedicine Boost As Zhuhai Links Up With Hong Kong and Macao","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-03-19","type":"regulatory","source":"Medical Dialogues","summary":"Zydus Lifesciences bags USFDA nod for prostate cancer drug Apalutamide - Medical Dialogues","headline":"Zydus Lifesciences bags USFDA nod for prostate cancer drug Apalutamide","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-03-05","type":"regulatory","source":"Medical Dialogues","summary":"USFDA nod to Zydus Lifesciences cancer drug Dasatinib - Medical Dialogues","headline":"USFDA nod to Zydus Lifesciences cancer drug Dasatinib","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOclhSbkJRLUJyWTFlZmFHUzRsZzZtYk5Yak1wRWpZcmp0XzBEdUdGYzdlWUV1UkJwUkhfZVdrVTFXS1NBZ2RwNUN6QUw0TlFoRXI4djhWT2x1d2gzWkxmQ1FqZ3BRM0FFNEdFVUl4cGt2U1BDcFc2REg2S0toR1F0WURlWkxzdEVVcjVGczJ6WEEzYTNZNlVtVGlWQTRnb3hyZEx6RUhVdw?oc=5","date":"2025-02-26","type":"pipeline","source":"BioSpace","summary":"U.S. Biotechnology Market Size to Hit USD 1,794.11 Billion by 203 - BioSpace","headline":"U.S. Biotechnology Market Size to Hit USD 1,794.11 Billion by 203","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-02-18","type":"pipeline","source":"Medical Dialogues","summary":"Zydus inks pact with Beihai Biotech for cancer drug Beizray commercialization in US - Medical Dialogues","headline":"Zydus inks pact with Beihai Biotech for cancer drug Beizray commercialization in US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxPNXAzblp1XzFrTldDaWcwa3UwVUZ3QlpGMHJYMVJrdDE5LUI5ZHJOV1Y4dDFqazRDeFBmTXpvSU96Mi1rSXpNaFZ4d0lMc1E3RWtvNjFscms3WDRsYnloS0VFeTlTc1U1VGlEaFo1RnBka2FRR3dtTV82N3ZsSXBxOGhLejZYY2tyWFBMRmpWeXFvbHdvUWFRQk1YSHgzdTc1Q3hYR2VDMHBFSm0wZWlmNFI5MDFCT3dxOVlWejY4WUhZVkdxYmVYNC15NFNfVVgtMVpmV29VNnctdDUwTU1PbDFLT0tYMS1sTGMxemlCaUhBQlFpMDN0UGJ5OE1rSUxIdmdhU2lXVDRLT0JYM203YlFoOHIybzdwNTU4U1pzOVhPM3BCVFE?oc=5","date":"2025-02-17","type":"pipeline","source":"Investment Guru","summary":"Zydus Lifesciences soars as its arm inks pact with Zhuhai Beihai Biotech CoZydus Lifesciences soars as its arm inks pact with Zhuhai Beihai Biotech Co - Investment Guru","headline":"Zydus Lifesciences soars as its arm inks pact with Zhuhai Beihai Biotech CoZydus Lifesciences soars as its arm inks pact","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-02-14","type":"pipeline","source":"ET Pharma","summary":"Zydus obtains Zhuhai Beihai Biotech’ cancer drug US commercial rights - ET Pharma","headline":"Zydus obtains Zhuhai Beihai Biotech’ cancer drug US commercial rights","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-02-14","type":"deal","source":"expresspharma.in","summary":"Zydus Lifesciences partners with Zhuhai Beihai Biotech for BEIZRAY commercialisation in the US - expresspharma.in","headline":"Zydus Lifesciences partners with Zhuhai Beihai Biotech for BEIZRAY commercialisation in the US","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-02-14","type":"pipeline","source":"The Economic Times","summary":"Zydus Lifesciences inks licensing pact with Zhuhai for cancer drug - The Economic Times","headline":"Zydus Lifesciences inks licensing pact with Zhuhai for cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQcENiMEJqQ3BXRVpPbHM1TFBhOHdCZEd2bUNDWTMyeFVURG5DOGVULUFocFhqTk1CNG45RGFvaWZUTEI5WFZPV1pEeV8yRXN6cmRYMUZTbzM3UWc5SjlTVTRERmlFejY4eFhCRXo0ekMxMWRsVXR1TFhPTTlqdnpxMDBjVEcyUnNTQm1ic0FGTVNJd1VKbV9QaDFPRjIxb3NvclhydFk3MGdBZw?oc=5","date":"2022-11-02","type":"pipeline","source":"BioWorld News","summary":"Beihai Biotech nets nearly ¥200M to support core asset development - BioWorld News","headline":"Beihai Biotech nets nearly ¥200M to support core asset development","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}